The starting dose is designed primarily to help the body adjust to treatment
While the rapid calorie restriction drives weight loss, it can also lead to nutritional deficiencies, muscle loss, and metabolic adaptation that makes weight regain more likely after stopping
These could indicate pelvic floor dysfunction or hormonal imbalances that require medical attention
On February 20, 2026, MEDVi received FDA Warning Letter #721455 for misbranding violations
Heavy metal analysis screens for toxic metal contamination that can occur during peptide synthesis or purification
Its receptor potency profile is precisely characterized: approximately 2.5-fold lower potency at the GLP-1 receptor than native GLP-1, 8.9-fold higher potency at the GIP receptor than native GIP, and 2.9-fold lower potency at the glucagon receptor than endogenous GCG